Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 26NIH 5NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Rhabdomyosarcoma 5Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Medulloblastoma 4Wilms Tumor 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Ganglioneuroblastoma 3Central Nervous System Neoplasms 3Burkitt Lymphoma 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Rhabdomyosarcoma, Embryonal 2Rectal Neoplasms 2Oropharyngeal Neoplasms 2Gliosarcoma 2Glioblastoma 2Endometrial Clear Cell Adenocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Astrocytoma 2Teratoma 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Spinal Cord Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1

Interventions

Cisplatin 41Radiotherapy 28Radiotherapy, Intensity-Modulated 12Fluorouracil 12Docetaxel 11Paclitaxel 10Cetuximab 10Carboplatin 8Immunohistochemistry 6Platinum 5Radiotherapy, Conformal 4Gene Expression Profiling 4Drug Therapy 4Chemotherapy, Adjuvant 4durvalumab 3Polymerase Chain Reaction 3In Situ Hybridization, Fluorescence 3Afatinib 31,2-diaminocyclohexaneplatinum II citrate 3vandetanib 2Taxes 2Surgical Procedures, Operative 2Reverse Transcriptase Polymerase Chain Reaction 2Radiation 2Panitumumab 2Nimorazole 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2In Situ Hybridization 2Fluorodeoxyglucose F18 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Squamous Cell Carcinoma of Head and Neck × Radiation × Clear all
NCT05721755 2026-05-05

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
290 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT03410615 2026-03-24

Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC

Canadian Cancer Trials Group

Phase 2 Active not recruiting
129 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡